[{"Assets_0_Q3_USD":7514553000.0,"CIK":"875320","CommonStockSharesConverted_0_Q3_shares":257265000.0,"CommonStockSharesOutstanding_0_Q3_shares":257265000.0,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":0.22,"EarningsPerShareBasic_3_Q3_USD":2.32,"EarningsPerShareDiluted_1_Q3_USD":0.22,"EarningsPerShareDiluted_3_Q3_USD":2.28,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"72193451271.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":1123322000.0,"NetIncomeLossConverted_1_Q3_USD":57518000.0,"NetIncomeLossConverted_3_Q3_USD":593576000.0,"OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","RevenuesConverted_1_Q3_USD":949828000.0,"RevenuesConverted_3_Q3_USD":2749556000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":5253394000.0,"Ticker":"VRTX","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":260473000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":260182000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":256946000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":256289000.0,"filed":"20191031","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2019.0","name":"VERTEX PHARMACEUTICALS INC \/ MA","period":"20190930","qtrs":"0","uom":"USD"}]